πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 13 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11932852

Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

Benitec IP Holdings Inc. Β· Granted Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11535851

Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

Benitec IP Holdings Inc. Β· Granted Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11234994

Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

Benitec Biopharma Limited Β· Granted Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11142765

Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

Benitec IP Holdings Inc. Β· Granted Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10898505

Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

Benitec Biopharma Limited Β· Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10000753

Age-related macular degeneration treatment

Benitec Biopharma Limited Β· Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9518260

Pain treatment

Benitec Biopharma Limited Β· Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9410154

HBV treatment

Benitec Biopharma Limited Β· Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9080174

HBV treatment

Benitec Biopharma Limited Β· Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8691967

Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

Benitec, Inc. Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8283461

Multiple promoter expression cassettes for simultaneous delivery of RNAi agents

Benitec, Inc. Β· Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8129510

Minigene expression cassette

Benitec Biopharma Limited Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7727970

Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted t

Benitec, Inc. Β· Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted